08.04.2010 – (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to delivering sophisticated key opinion leader (KOL) research solutions to the biopharmaceutical industry, announces the commencement of an ophthalmology key opinion leader assessment for a top global biopharmaceutical company.
The client company, currently developing a large portfolio of new medicines, has contracted the firm for its seventh major research assessment of the Canadian medical community. Thought Leader Select will utilize its deep profiling methodology to deliver detailed information on the skills and experiences of leading eye doctors across Canada’s ten provinces.
In addition to the KOL profiles, Thought Leader Select will also deliver access to its exclusive web-based expert tool used to optimize physician teams for a variety of development activities.
“We’re obviously quite happy to begin our seventh project for this very important and much valued client,” stated Neil Mellor, Thought Leader Select’s business development consultant for North America. “While we’ve worked in dozens of therapeutic areas and disease states, we really know the ophthalmology landscape quite well. That translates into superior work that drives value for our clients and their brands.”
About Thought Leader Select
Thought Leader Select, based in the Research Triangle area of North Carolina, delivers a variety of solutions—research, technology tools and focused advice/consulting—for more effective thought leader engagement in the healthcare industry. Thought Leader Select’s groundbreaking work bridges the areas of research, communications and technology. With an expanded global presence, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.
Director of Global Marketing and Client Relations